2018
Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors
Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors. Annals Of Surgical Oncology 2018, 25: 3613-3620. PMID: 30182331, DOI: 10.1245/s10434-018-6741-x.Peer-Reviewed Original ResearchConceptsRepeat transarterial chemoembolizationMetastatic neuroendocrine tumorsTransarterial chemoembolizationPancreastatin levelsNeuroendocrine tumorsOverall survivalPrognostic impactImproved overall survivalProgressive liver diseaseFirst transarterial chemoembolizationWorse overall survivalUseful prognostic indicatorLong-term survivalPg/mLConclusionsFor patientsPost TACECarcinoid syndromeTACE treatmentLiver metastasesPatient demographicsImproved survivalLiver diseasePoor outcomePrognostic indicatorResultsA total
2016
Mortality and readmission of outcomes after discharge from the surgical intensive care unit to long-term, acute-care hospitals
Nguyen MC, Strosberg DS, Jones TS, Bhakta A, Jones EL, Lyaker MR, Byrd CA, Sobol C, Eiferman DS. Mortality and readmission of outcomes after discharge from the surgical intensive care unit to long-term, acute-care hospitals. Surgery 2016, 161: 1367-1375. PMID: 28027819, DOI: 10.1016/j.surg.2016.11.007.Peer-Reviewed Original ResearchConceptsSurgical intensive care unitIntensive care unitAcute care hospitalsIntensive care unit hospitalizationCare unitGreater oddsReadmission ratesMortality ratePost-intensive care unit recoveryEnd-stage renal diseaseTertiary care medical centerMultiple logistic regression analysisVascular surgery patientsAcute renal failureHigh complication rateHistory of cancerEnteral feeding accessLogistic regression analysisOngoing medical needsHigher readmissionComplication rateFrequent complicationRenal failureSurgery patientsPrimary outcomeAgency for Healthcare Research and Quality (AHRQ) Patient Safety Indicator for Postoperative Respiratory Failure (PSI 11) does not identify accurately patients who received unsafe care
Nguyen MC, Moffatt-Bruce SD, Strosberg DS, Puttmann KT, Pan YL, Eiferman DS. Agency for Healthcare Research and Quality (AHRQ) Patient Safety Indicator for Postoperative Respiratory Failure (PSI 11) does not identify accurately patients who received unsafe care. Surgery 2016, 160: 858-868. PMID: 27528212, DOI: 10.1016/j.surg.2016.05.032.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedFemaleHealth Services ResearchHospital MortalityHumansMaleMiddle AgedPatient SafetyPostoperative ComplicationsQuality Indicators, Health CareRespiratory InsufficiencyRetrospective StudiesRisk AssessmentSafety ManagementSeverity of Illness IndexSurgical Procedures, OperativeSurvival RateUnited StatesUnited States Agency for Healthcare Research and QualityConceptsPostoperative respiratory failureRespiratory failureUnsafe carePositive predictive valueHealthcare ResearchClinical factorsPredictive valueQuality Patient Safety IndicatorsDiseases-9 codesPatient safety indicatorsElectronic medical recordsPatient safety eventsTrue positive casesInpatient electronic medical recordHospital performance measuresClinical characteristicsMedical recordsOperative procedureExclusion criteriaInternational ClassificationSafety eventsCareDocumentation errorsPatientsIndependent review